eicosapentaenoic acid ethyl ester has been researched along with Aging in 1 studies
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
"The elderly patients with type 2 diabetes suffer more adverse drug events than young adults due to pharmacokinetic and pharmacodynamic changes associated with aging." | 1.48 | Benefits of combination low-dose pioglitazone plus fish oil on aged type 2 diabetes mice. ( Chiba, K; Hirako, S; Iizuka, Y; Kim, H; Matsumoto, A; Wada, M, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iizuka, Y | 1 |
Kim, H | 1 |
Hirako, S | 1 |
Chiba, K | 1 |
Wada, M | 1 |
Matsumoto, A | 1 |
1 other study available for eicosapentaenoic acid ethyl ester and Aging
Article | Year |
---|---|
Benefits of combination low-dose pioglitazone plus fish oil on aged type 2 diabetes mice.
Topics: Aging; Animals; Diabetes Mellitus, Type 2; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosap | 2018 |